Skip to main content
Premium Trial:

Request an Annual Quote

Kim Popovits, Wendy Yarno

MyoKardia has appointed Kim Popovits and Wendy Yarno to its board of directors. Popovitz currently serves on the boards of the American Clinical Laboratory Association, California Life Sciences Association, Personalized Medicine Coalition, and ZS Pharma. She has served as Genomic Health's CEO and president since 2009, and chairman of the company's board since 2013. Yarno is the non-executive chairman of the board of Aratana Therapeutics and has served on the boards of ADial PHarmaceuticals, Durata Therapeutics, Medivation, St. Jude Medical, and PluroGen Therapeutics. She is also a retired chief marketing officer for Merck.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.